What is Avarint?
Avarint is a client-focused entity dedicated to advancing research, development, testing, and systems integration, with a pronounced emphasis on innovation and cutting-edge technology. The company distinguishes itself by providing independent, third-party testing services across chemical and biological sciences. Furthermore, Avarint develops sophisticated modeling and simulation systems specifically designed for C4ISR applications. As a subsidiary of CUBRC, Inc., Avarint benefits from an extensive legacy of over 40 years in engineering and testing services, enabling it to deliver highly customized solutions that precisely meet client requirements and ensure responsive service delivery.
How much funding has Avarint raised?
Avarint has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Avarint
PPP
Public-Private Partnership
What's next for Avarint?
The recent major strategic investment signals a pivotal phase for Avarint, likely enabling accelerated expansion of its R&D capabilities and the enhancement of its independent testing services. This capital infusion is expected to fuel further innovation in modeling and simulation systems for C4ISR, potentially broadening its market reach and solidifying its position as a key player in technology-driven solutions. The company's strategic alignment with CUBRC, Inc. provides a robust foundation for continued growth and the development of advanced technological offerings.
See full Avarint company page
